Well-funded stealthy biotech startup Nautilus hires former Smartsheet, Isilon, GenapSys execs

Well-funded stealthy biotech startup Nautilus hires former Smartsheet, Isilon, GenapSys execs

is getting the band again collectively at his secretive new biotech startup . The corporate is beefing up its govt workforce with three new additions:

Mowry and Blessington beforehand labored with Patel at Isilon Methods, a Seattle startup he co-founded and offered to EMC for $2.5 billion in 2010. Mowry was most not too long ago at Igneous and hung out at Amazon Internet Providers. Blessington was beforehand a advertising and marketing and communications chief at Smartsheet and ExtraHop Networks.

Sankar is a former product improvement chief at GenapSys, and led engineering at Solexa/Illumina.

The three execs will assist Nautilus additional develop and market its next-generation platform to check the human proteome, the physique’s full set of proteins.

“It undoubtedly helps us speed up our efforts,” Patel advised GeekWire.

Patel and his co-founder , a Stanford professor and most cancers researcher, have been largely under-the-radar for the previous 4 years engaged on Nautilus. Now they’re shortly constructing out their workforce,

The startup has an bold plan to vary the way in which therapeutics are developed, in search of to catalyze a brand new wave of medical therapy.

Nautilus, co-located in Seattle and Silicon Valley, is constructing a mixture of {hardware} and software program to extra precisely and effectively quantify the human proteome.

Whereas it’s now comparatively easy and low cost to research a genome with a drop of blood, the identical progress hasn’t been made with the proteome — and that’s the chance Nautilus is trying to seize with what it describes as quicker, cheaper, and extra exact proteomic applied sciences.

There are a number of use circumstances for the corporate’s expertise, together with therapeutics improvement. In some methods, Nautilus desires to democratize proteomics, much like how firms corresponding to publicly-traded biotech big Illumina have completed with genomics.

“It’s an extremely thrilling house,” stated Blessington, who beforehand spent 5 years at collaboration software program big Smartsheet, together with its transition to a public firm in 2018.

Blessington pointed to the current information about DeepMind, Google’s deep-learning program .

“There’s a rising awakening in regards to the potential of protein evaluation to make a distinction in folks’s lives,” he stated.

Patel added that the pandemic has shone a bigger highlight on the whole therapeutics market with the speedy improvement of vaccines. “That’s good for all gamers within the market,” he stated.

Nautilus final yr raised $76 million from an all-star group of buyers together with Vulcan Capital, the multi-billion-dollar holding firm created by the late Microsoft co-founder Paul Allen; Bezos Expeditions, the VC arm of Amazon founder Jeff Bezos; and prime biotech agency Perceptive Advisors and Defy Companions. Earlier backers AME Cloud Ventures, Andreessen Horowitz, Bolt, and Madrona Enterprise Group invested more money.

The corporate now has 62 workers. , vice chairman of operations, is one other former Isilon exec. The C-suite additionally consists of , chief enterprise officer who beforehand led the brand new and rising markets enterprise at Illumina.

Related posts

Which Uber ride do you prefer? Seattle driver offers menu with comedy, compassion, silence and more


Chaos takes control: HBO teases new season of ‘Westworld,’ as the androids come back online


Hillary Clinton taps Google exec as her chief technology officer